Skip to content

Author

Francesca Piazza

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Role of maintaining the TKI backbone in oncogene-driven NSCLC after progression.

Tyrosine kinase inhibitors (TKIs) have marked a turning point in the treatment of oncogene-addicted non-small cell lung cancer (NSCLC), offering unprecedented efficacy. Yet, most tumors eventually develop resistance and progress, often prompting discontinuation of the targeted agent and a switch to non-targeted therapi...

Francesca Piazza, Rishi Sharma, Alessandra Esposito et al. · 0 citations
#artificial intelligence Open access Sep 2026

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

In a large international real-world study of non-small cell lung cancer, a multimodal explainable AI model outperformed established biomarkers for immunotherapy outcome prediction and improved physician decision-making.

A. Prelaj, V. Mišković, Matteo Sacco et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.